[1] WORLD HEALTH ORGANIZATION.Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern[EB/OL]. [2021-11-26].https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. [2] KIM MK, LEE B, CHOI YY, et al.Clinical Charac teristics of 40 Patients Infected With the SARS-CoV-2 Omicron Variant in Korea[J]. Korean Med Sci, 2022, 37(3):e31. [3] 中华人民共和国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第九版)[EB/OL].[2022-03-15].http://www.nhc.gov.cn/yzygj/s7653p/202001/4294563ed35b43-209b31739bd0785e67.shtml. [4] 云永兴, 王立非, 安超, 等. 人工智能在新型冠状病毒肺炎临床分型中的应用[J]. 实用放射学杂志, 2021, 37(2):207-210. [5] CHEN J, GAO K, WANG R, et al.Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies[J]. Chem Sci, 2021, 12(20):6929-6948. [6] KARIM SSA, KARIM QA.Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic[J]. Lancet, 2021, 398(10317):2126-2128. [7] 廖康生,卢洪洲. 新型冠状病毒奥密克戎变异株的研究进展:对其科学防控措施的启示[J/CD]. 新发传染病电子杂志,2022,7(1):1-5. [8] WORLD HEALTH ORGANIZATION.Omicron spreads but severe cases remain low in South Africa[EB/OL]. [2021-12-22].https://www.afro.who.int/news/omicron-spreads-severe-cases-remain-low-south-africa. [9] MASLO C, FEIEDLAND R, TOUBKIN M, et al.Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves[J]. JAMA, 2022, 327(6):583-584. [10] EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL. Assessment of the further emergence and potential impact of the SARS-CoV-2 omicron variant of concern in the context of ongoing transmission of the Delta variant of concern in the EU/EEA, 18th[EB/OL].[2021-12-05]. https://www.ecdc.europa.eu/sites/default/files/-documents/covid-19-assessment-further-emergence-omicron-18th-risk-assessment-december-2021.pdf. [11] 郑丹文, 翁衡, 刘云涛, 等. 广州Delta新冠病毒变异株感染的新型冠状病毒肺炎临床特征的真实世界研究[J]. 中华急诊医学杂志, 2021, 30(10):1220-1228. [12] 何梦璋, 杨崇艳, 吴雄婷, 等. 重症和非重症新冠肺炎患者的临床特征对比及危险因素分析[J/CD]. 中华临床实验室管理电子杂志, 2021, 9(2):110-117. [13] 冯世艳, 王凤新, 陈莉, 等. 新型冠状病毒肺炎重症患者的炎性指标及T淋巴细胞亚群情况分析[J]. 中国病毒病杂志, 2020, 10(6):435-438. [14] 胡金曹, 沈瀚,陶月, 等. 新型冠状病毒感染者咽拭子病毒载量与抗体水平的动态分析[J]. 东南大学学报(医学版), 2021, 40(5):645-652. [15] 中华医学会放射学分会. 新型冠状病毒肺炎的放射学诊断:中华医学会放射学分会专家推荐意见(第一版)[J]. 中华放射学杂志, 2020, 54(4): 279-285. [16] 余成成, 杨彦鸿, 胡天丽, 等. 新型冠状病毒B.1.617.2变异株感染者高分辨率CT与临床特点[J]. 中华放射学杂志, 2021, 55(10):1054-1058. [17] 杜丹,谢元亮,李惠,等. 人工智能定量测量对新型冠状病毒肺炎患者胸部评估价值CT炎性病灶动态变化的评估价值[J]. 中华放射学杂志,2021,55(3):250-256. [18] PHAN LT, NGUYEN TV, LUONG QC, et al.Importation and human to human transmission of a novel coronavirus in vietnam[J]. N Engl J Med, 2020, 382(9): 872-874. [19] 甘清鑫,刘晋新,杨彦鸿,等.白细胞介素-6与新型冠状病毒B.1.617.2变异株引起肺损伤相关性的人工智能定量分析[J/CD].新发传染病电子杂志,2021,6(3):172-176. [20] RANA A, CAROLINE SF, ZHANG X.The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters[J]. Antiviral Res, 2022, 198:105253. [21] LONG B, CHAVEZ S, CARIUS BM, et al.Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation[J]. Am J Emerg Med, 2022, 56:158-170. |